Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Net Cash Flow (2016 - 2025)

Orthopediatrics has reported Net Cash Flow over the past 10 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $2.7 million for Q4 2025, up 138.5% from a year ago — trailing twelve months through Dec 2025 was -$24.5 million (down 289.59% YoY), and the annual figure for FY2025 was -$24.5 million, down 289.59%.
  • Net Cash Flow for Q4 2025 was $2.7 million at Orthopediatrics, up from -$27.7 million in the prior quarter.
  • Over the last five years, Net Cash Flow for KIDS hit a ceiling of $25.8 million in Q1 2023 and a floor of -$27.7 million in Q3 2025.
  • Median Net Cash Flow over the past 5 years was -$362500.0 (2022), compared with a mean of -$463950.0.
  • Biggest five-year swings in Net Cash Flow: tumbled 1668.57% in 2022 and later skyrocketed 2082.01% in 2024.
  • Orthopediatrics' Net Cash Flow stood at $1.7 million in 2021, then tumbled by 1668.57% to -$26.6 million in 2022, then soared by 174.3% to $19.8 million in 2023, then plummeted by 135.11% to -$6.9 million in 2024, then surged by 138.5% to $2.7 million in 2025.
  • The last three reported values for Net Cash Flow were $2.7 million (Q4 2025), -$27.7 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.